Advertisement
Canada markets open in 3 hours 11 minutes
  • S&P/TSX

    21,639.10
    -59.00 (-0.27%)
     
  • S&P 500

    5,431.60
    -2.14 (-0.04%)
     
  • DOW

    38,589.16
    -57.94 (-0.15%)
     
  • CAD/USD

    0.7275
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    78.43
    -0.02 (-0.03%)
     
  • Bitcoin CAD

    90,348.95
    -830.33 (-0.91%)
     
  • CMC Crypto 200

    1,359.35
    -28.81 (-2.08%)
     
  • GOLD FUTURES

    2,336.20
    -12.90 (-0.55%)
     
  • RUSSELL 2000

    2,006.16
    -32.75 (-1.61%)
     
  • 10-Yr Bond

    4.2130
    -0.0250 (-0.59%)
     
  • NASDAQ futures

    19,704.50
    +19.00 (+0.10%)
     
  • VOLATILITY

    13.19
    +0.53 (+4.19%)
     
  • FTSE

    8,136.21
    -10.65 (-0.13%)
     
  • NIKKEI 225

    38,102.44
    -712.12 (-1.83%)
     
  • CAD/EUR

    0.6793
    -0.0005 (-0.07%)
     

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BellRing Brands (BRBR) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.

BellRing Brands is one of 1047 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BellRing Brands is currently sporting a Zacks Rank of #1 (Strong Buy).

Over the past 90 days, the Zacks Consensus Estimate for BRBR's full-year earnings has moved 6.9% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

ADVERTISEMENT

According to our latest data, BRBR has moved about 6.6% on a year-to-date basis. At the same time, Medical stocks have gained an average of 4.5%. This means that BellRing Brands is performing better than its sector in terms of year-to-date returns.

Another Medical stock, which has outperformed the sector so far this year, is DaVita HealthCare (DVA). The stock has returned 26.2% year-to-date.

In DaVita HealthCare's case, the consensus EPS estimate for the current year increased 4.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, BellRing Brands belongs to the Medical - Products industry, a group that includes 91 individual stocks and currently sits at #95 in the Zacks Industry Rank. This group has gained an average of 2.7% so far this year, so BRBR is performing better in this area.

In contrast, DaVita HealthCare falls under the Medical - Outpatient and Home Healthcare industry. Currently, this industry has 19 stocks and is ranked #53. Since the beginning of the year, the industry has moved +7.2%.

Investors with an interest in Medical stocks should continue to track BellRing Brands and DaVita HealthCare. These stocks will be looking to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

BellRing Brands Inc. (BRBR) : Free Stock Analysis Report

DaVita Inc. (DVA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research